transmitted by means of respiratory droplets. • the virus replicates in the nasopharynx and regional lymph nodes, resulting in viremia. The virus then may spread to the skin, CNS, synovial fluid, and transplacentally to a developing fetus History
• The incubation period of rubella is 14-23 days.
• The prodrome is characterized by the following: • Malaise • Fever • Anorexia • Headache • Mild conjunctivitis • Rhinorrhea The rash develops within 1-5 days of symptom onset, starting on the face and forehead and spreading caudally to involve the trunk and extremities. • The rash tends to clear in the same order as it appeared. • The rash may be pruritic, but it usually resolves within 3 days without residua. Physical
• Lymphadenopathy may be present,
particularly in the posterior auricular, posterior cervical, and suboccipital chains. • The rash consists of pink macules and papules, which may become confluent, resulting in a scarlatiniform eruption. • Petechiae of the soft palate, known as the Forchheimer sign, may be present. The diagnosis of rubella • clinical • seroconversion in response to rubella antigens may confirm it Antibodies are often present shortly after the rash appears and increase in titer during the next 2-3 weeks. Elevated levels of immunoglobulin M (IgM) antibodies are particularly helpful findings in newborns. IgM antibodies do not cross the placenta and indicate a recent infection acquired after birth COMPLICATIONS • Infection in healthy children or young adults is generally self- limited and without sequelae.
• The most common complications
• arthropathies of the fingers, wrists, and knees that can persist for a year or more. • thrombocytopenia with purpura and hemorrhage is a rare complication of rubella. • congenital rubella syndrome is associated with malformations of multiple organ systems including the CNS and cardiac, ocular, and skeletal systems. Infants with congenital rubella syndrome who survive into adulthood may be plagued by autoimmune disorders and dysgammaglobulinemia. • Damage to the fetus is most likely when maternal infection occurs during the first 2 months of pregnancy, although there is risk associated with infection up to 5 months. Treatment • No antiviral therapy for rubella is available. • Treatment is supportive